These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1535785)

  • 1. Alleviation of immunosuppression in vitro by recombinant platelet factor 4.
    Katz IR; Thorbecke GJ; Zucker MB
    Int Immunol; 1992 Feb; 4(2):183-90. PubMed ID: 1535785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
    Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity.
    Maione TE; Gray GS; Hunt AJ; Sharpe RJ
    Cancer Res; 1991 Apr; 51(8):2077-83. PubMed ID: 1706960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal protective action of histamine against gastric lesions induced by HCl in rats: importance of antigastric motor activity mediated by H2-receptors.
    Takeuchi K; Nishiwaki H; Okada M; Okabe S
    J Pharmacol Exp Ther; 1988 May; 245(2):632-8. PubMed ID: 2966857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells.
    Sawutz DG; Kalinyak K; Whitsett JA; Johnson CL
    J Pharmacol Exp Ther; 1984 Oct; 231(1):1-7. PubMed ID: 6208354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory activity of peptides related to platelet factor 4.
    Zucker MB; Katz IR; Thorbecke GJ; Milot DC; Holt J
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7571-4. PubMed ID: 2678107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory properties of platelet factor 4: prevention of concanavalin A suppressor-induction in vitro and augmentation of an antigen-specific delayed-type hypersensitivity response in vivo.
    Gregg EO; Yarwood L; Wagstaffe MJ; Pepper DS; Macdonald MC
    Immunology; 1990 Jun; 70(2):230-4. PubMed ID: 2142674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention by a platelet-derived factor (platelet factor 4) of induction of low dose tolerance to pneumococcal polysaccharides.
    Yin JZ; Zucker MB; Clarke D; Bell MK; Thorbecke GJ
    Cell Immunol; 1988 Sep; 115(2):221-7. PubMed ID: 3409328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors.
    Sedor JR; Abboud HE
    J Clin Invest; 1985 May; 75(5):1679-89. PubMed ID: 2582001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo immune response suppression by the supernatant from concanavalin A-activated spleen cells.
    Reinertsen JL; Steinberg AD
    J Immunol; 1977 Jul; 119(1):217-22. PubMed ID: 326957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4.
    Daly TJ; LaRosa GJ; Dolich S; Maione TE; Cooper S; Broxmeyer HE
    J Biol Chem; 1995 Oct; 270(40):23282-92. PubMed ID: 7559482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for histamine H1 and H2 receptors in guinea-pig oxyntic cells.
    Vinik AI; Heldsinger AA; Skoglund ML
    J Pharmacol Exp Ther; 1983 Oct; 227(1):115-21. PubMed ID: 6137553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effect of centrally administered cimetidine and dimaprit in the rat.
    Netti C; Bossa R; Galatulas I; Sibilia V; Pecile A
    Pharmacology; 1984; 28(5):262-7. PubMed ID: 6233621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicutaneous immunization induces alphabeta T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta.
    Szczepanik M; Bryniarski K; Tutaj M; Ptak M; Skrzeczynska J; Askenase PW; Ptak W
    Immunology; 2005 May; 115(1):42-54. PubMed ID: 15819696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of in vitro cellular immune response by histamine agonists or antagonists in murine species.
    French S; Walker M; Susskind B; Faanes R
    Arzneimittelforschung; 1985; 35(1A):390-4. PubMed ID: 3157386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of reactive nitrogen intermediates and transforming growth factor-beta produced by immunosuppressive macrophages in the expression of suppressor activity against T cell proliferation induced by TCR stimulation.
    Shimizu T; Cai S; Tomioka H
    Cytokine; 2005 Apr; 30(1):7-13. PubMed ID: 15784407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H2 receptors mediate cyclical chloride secretion in guinea pig distal colon.
    Wang YZ; Cooke HJ
    Am J Physiol; 1990 Jun; 258(6 Pt 1):G887-93. PubMed ID: 2141762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
    Maier T; Holda JH
    J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4.
    Kolber DL; Knisely TL; Maione TE
    J Natl Cancer Inst; 1995 Feb; 87(4):304-9. PubMed ID: 7707422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The release of transforming growth factor-beta following haemorrhage: its role as a mediator of host immunosuppression.
    Ayala A; Meldrum DR; Perrin MM; Chaudry IH
    Immunology; 1993 Jul; 79(3):479-84. PubMed ID: 8406575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.